InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with our subsidiary, BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.inmedpharma.com. Nasdaq: INM
View Top Employees from InMed PharmaceuticalsWebsite | http://www.inmedpharma.com |
Ticker | INM |
Revenue | $1 million |
Employees | 23 (23 on RocketReach) |
Founded | 1981 |
Address | 815 West Hastings, St #310, Vancouver, British Columbia V6C 1B4, CA |
Phone | (604) 669-7207 |
Fax | (604) 683-2506 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Healthcare |
Web Rank | 6 Million |
Keywords | Inm-085 Drug, Inmed Pharmaceuticals, Inmedpharm, Inmed Biopharm |
Competitors | Pharmazz Inc, Precision Biologics, Soligenix, Inc., Trevena Inc |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular InMed Pharmaceuticals employee's phone or email?
The InMed Pharmaceuticals annual revenue was $1 million in 2024.
Michael Woudenberg is the COO of InMed Pharmaceuticals.
23 people are employed at InMed Pharmaceuticals.
InMed Pharmaceuticals is based in Vancouver, British Columbia.
The NAICS codes for InMed Pharmaceuticals are [325, 32, 54, 541, 32541, 3254].
The SIC codes for InMed Pharmaceuticals are [283, 28].